Bessent defends Warsh, saying markets are going through ‘detox’ from too much Fed guidance

IDEXX Laboratories jumps 5% on strong results, raised guidance

Whirlpool expects ~4% 2026 ongoing EBIT margin and <$5B net debt exit as pricing actions compound

InfuSystem anticipates 6% to 8% annual revenue growth as wound care expands and adjusted EBITDA margin targets low to mid-20%

Otter Tail initiates 2026 adjusted EPS guidance of $5.68 to $6.08 while reaffirming 10% 5-year rate base CAGR